(Q34647610)

3 August 2017

1 reference

title

Nonallergic angioedema: role of bradykinin (English)

1 reference

3 August 2017

Bas M

1

1 reference

3 August 2017

Adams V

2

1 reference

3 August 2017

Suvorava T

3

1 reference

3 August 2017

Niehues T

4

1 reference

3 August 2017

Hoffmann TK

5

1 reference

3 August 2017

Kojda G

6

1 reference

3 August 2017

publication date

1 August 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

62

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

842-856

1 reference

Evaluation and management of angioedema of the head and neck

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Drug-induced angioedema without urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

21 January 2018

Aspirin-sensitive asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Increased sensitivity to bradykinin among African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Does kinin mediate the hypotensive action of angiotensin converting enzyme (ACE) inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Synthesis of kallikreins by rat kidney slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Competitive antagonists of bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Bradykinin receptors: characterization, distribution and mechanisms of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Expression cloning of a rat B2 bradykinin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Structure and chromosomal localization of the gene (BDKRB2) encoding human bradykinin B2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Genomic DNA sequence, expression, and chromosomal localization of the human B1 bradykinin receptor gene BDKRB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Induction of beta 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Role of the bradykinin B2 receptor in the maturation of blood pressure phenotype: lesson from transgenic and knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Role of endogenous bradykinin in human coronary vasomotor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Bradykinin receptors: pharmacological properties and biological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Inhibition of bradykinin- and kallikrein-induced cerebral arteriolar dilation by a specific bradykinin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Bradykinin receptor ligands: therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

A novel protein-protein interaction between a G protein-coupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion: role of adenosine A1/A3 and bradykinin B2 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Bradykinin and changes in microvascular permeability in the hamster cheek pouch: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

In vivo B1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Kinins and their receptors in hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Regulation of bone metabolism by the kallikrein-kinin system, the coagulation cascade, and the acute-phase reactants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

The role of bradykinin B1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Kinin receptors in pain and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Overexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

[Hereditary angioedema in the German-speaking region]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

C1 inhibitor: molecular and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Formation of bradykinin: a major contributor to the innate inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Acquired C1 esterase inhibitor deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Lymphoma-associated paraneoplastic angioedema with normal C1-inhibitor activity: does danazol work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Characterisation of a new C1 inhibitor mutant in a patient with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Plasma bradykinin in angio-oedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Losartan increases bradykinin levels in hypertensive humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Angiotensin receptors and their antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Controversies in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Sex hormones in hereditary angioneurotic oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Increased C-reactive protein in ACE-inhibitor-induced angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

The pathophysiology of hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

C1 inhibitor deficiency: consensus document

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Images in clinical medicine. Angioedema of the arytenoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Clinical management of hereditary angio-oedema in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Tranexamic acid: a review of its use in surgery and other indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Take the side-effects of drugs into account

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Angioedema due to angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

Bradykinin Stimulates the Tyrosine Phosphorylation and Bradykinin B2 Receptor Association of Phospholipase Cγ1 in Vascular Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01427.X

10.1111/J.1398-9995.2007.01427.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference